XML 130 R109.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Business Segments (Information on Operating and Reportable Segments) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Feb. 28, 2023
Feb. 28, 2022
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Segment Reporting Information, Profit (Loss):          
Total segment revenues     $ 1,125,357 $ 1,127,725 $ 1,086,812
Cost of sales     500,909 502,431 466,166
Gross profit     624,448 625,294 620,646
Advertising and marketing     153,315 145,061 157,343
Contribution margin     471,133 480,233 463,303
Other operating expenses     128,704 502,648 133,384
Operating income (loss)     342,429 (22,415) 329,919
Impairment of intangible assets   $ 700   321,412  
Goodwill, impairment loss $ 48,800     48,805  
North American OTC Healthcare          
Segment Reporting Information, Profit (Loss):          
Total segment revenues     958,260 973,774 967,881
Cost of sales     429,361 441,844 419,162
Gross profit     528,899 531,930 548,719
Advertising and marketing     131,494 123,926 138,714
Contribution margin     397,405 408,004 410,005
Goodwill, impairment loss       48,805  
North American OTC Healthcare | Intersegment Eliminations          
Segment Reporting Information, Profit (Loss):          
Total segment revenues     3,700 4,300 3,000
International OTC Healthcare          
Segment Reporting Information, Profit (Loss):          
Total segment revenues     167,097 153,951 118,931
Cost of sales     71,548 60,587 47,004
Gross profit     95,549 93,364 71,927
Advertising and marketing     21,821 21,135 18,629
Contribution margin     $ 73,728 72,229 $ 53,298
Goodwill, impairment loss   $ 300   $ 0